PETX

Aratana Therapeutics, Inc. Press Releases

$13.49
*  
0.55
4.25%
Get PETX Alerts
*Delayed - data as of Nov. 24, 2014 13:08 ET  -  Find a broker to begin trading PETX now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    PETX Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
Aratana Therapeutics to Present at Jefferies Global Healthcare Conference
11/17/2014 2:12:00 PM - PR Newswire


Aratana Therapeutics Reports Third Quarter 2014 Results
11/10/2014 4:31:00 PM - PR Newswire
▲14.32 % Price Change since this news event. The Volume Ratio is 1.67.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana Therapeutics Inc. to Report Third Quarter Financial Results
11/4/2014 4:55:00 PM - PR Newswire
▲15.69 % Price Change since this news event. The Volume Ratio is 0.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Advaxis's ADXS-cHER2 Immunotherapy Demonstrates T-Cell Immune Response in Data Analysis From Canine Osteosarcoma Study
10/30/2014 7:30:00 AM - GlobeNewswire


Aratana Therapeutics and Atopix Complete Global Licensing Agreement for Development and Commercialization of Novel Atopic Dermatitis Program
10/13/2014 8:00:00 AM - PR Newswire
▲33.56 % Price Change since this news event. The Volume Ratio is 0.89.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Aratana Therapeutics Announces Presentation of Clinical Data at Annual Veterinary Cancer Society Meeting
10/10/2014 9:25:00 AM - PR Newswire
▲33.43 % Price Change since this news event. The Volume Ratio is 1.04.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Advaxis's Cancer Immunotherapy Featured on Fox News
9/26/2014 7:30:00 AM - GlobeNewswire


Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters'' Option to Purchase Additional Shares
9/18/2014 6:30:00 PM - PR Newswire


Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares
9/18/2014 6:30:00 PM - PR Newswire


Aratana Therapeutics, Inc. Announces Pricing of Public Offering
9/17/2014 9:20:00 AM - PR Newswire


Aratana Therapeutics, Inc. Announces Proposed Public Offering
9/16/2014 4:01:00 PM - PR Newswire


Aratana Therapeutics Reports Positive Effectiveness Data from Pilot Field Study of Bupivacaine Extended-Release Injectable Suspension (AT-003)
9/9/2014 7:00:00 AM - PR Newswire


Aratana Therapeutics to Present at Morgan Stanley Global Healthcare Conference
9/5/2014 8:15:00 AM - PR Newswire